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35 ( 7 ) In a previous report,2) it was shown that synthetic alkyl glycosides formed lamellar vesicles like phosphatidylcholine vesicles (liposomes), and the preparation and physical properties of these vesicles were described. The targeting efficiency of the vesicles based on palmitoyl galactoside to the liver was also reported.3) Application of synthetic acyl amino acids and acyl peptides was attempted in the present study, and the preparation of the vesicles and glutathione-transporting ability of the acyl glutathione vesicles are described here.
Yatvin et al.4) reported pH-sensitive liposomes composed of synthetic palmitoyl homocysteine. This is an example of application of an acyl amino acid as a liposomal component. If acyl amino acids form lamellar liposome-like vesicles, as alkyl glycosides do, they could be useful for the development of effective drug carriers or functional liposomes, because amino acids have various functional groups and it should be possible to carry out chemical modifications on the liposomal surface. Neuman and Ringsdorf5) prepared liposomes composed of amino acids coupled with a long hydrocarbon chain. They attempted to stabilize the liposomes by the formation of amide bonds on the surface of the liposomes.
In this report, preparation of liposomes based on N-palmitoyl amino acids and the encapsulation capacities of the liposomes were investigated, and the stability in plasma and disposition in vivo of palmitoyl serine liposomes were examined as an example.
Many applications of lipophilized peptides which are biologically active, such as muramyl dipeptide (MDP), have recently been attempted.6) Liposomes injected in vivo were phagocytosed by macrophages and the peptide then activated the macrophages. We focussed on glutathione, which has an important role in detoxication in the liven') Glutathione is not readily taken up by the liver in free form,8 but esters of glutathione are taken up more effectively. Anderson et al.") studied the uptake of glutathione monoethyl ester by tissues and its conversion to glutathione. On the other hand, it is known that substantial fractions of intravenously injected liposomes are taken up by the liver,") probably mainly by the Kupffer cells. However, small liposomes such as small unilamellar vesicles (SUV) may pass through the fenestration of the liver sinusoids and could reach the parenchymal cells.12'13) Malnoe et al.") studied the effect of liposomal entrapment on the protective action of glutathione against acetaminophen-induced liver necrosis. Wendel et al. reported") the transport of glutathione by liposomes encapsulating glutathione in the aqueous phase, but a part of the aqueous contents was apparently released very rapidly in the blood. 16'17) Further, the multilamellar vesicles (MLV) that they used may not be able to be taken up by the parenchymal cells, because they cannot pass through the fenestration and thus cannot reach the cells. 12 The use of small liposomes might not improve the situation, because their capacity for glutathione transport would be small.
In this study, we attempted to transport glutathione into the hepatocytes by using small vesicles composed of acyl glutathione. The effectiveness of transport was assessed in terms of the suppressing effect on the increase of plasma glutamate oxaloacetate transaminase (GOT) induced by a high dose of acetaminophen." The stability in plasma and disposition in viv of the palmitoyl glutathione liposomes were also examined.
Experimental

Materials
Palmitic acid, L-serine and L-lysine were purchased from Nakarai Chem. Ltd. (Kyoto). Glycine, Lcystine and L-glutamic acid were from Kanto Chem. Co., (Tokyo). N-Hydroxysuccinimide and dicyclohexylcarbodiimide were of special grade for peptide synthesis, and were purchased from Nakarai Chem. Ltd. 5(6)-Carboxyfluorescein (Kodak, Rochester, N.Y.) was used without purification. Hydrogenated egg-phosphatidylcholine and glutathione were gifts from Nippon Fine Chem. Co., (Osaka) and Yamanouchi Pharm. Co., (Tokyo), respectively. All other chemicals and reagents were as described in the previous papers.2 ' 3) Synthesis of N-Palmitoyl Amino Acids N-Hydroxysuccinimide ester of palmitic acid (PS) was prepared and crystallized (yield 67.5%, mp 90 °C) as described by Lapidot Synthesis of N-Palmitoyl Glutathionc Glutathione (GSH) was oxidized by air in alkaline solution (NaHCO3) at 40 °C by the method of Aoyagi et al.') Oxidized glutathione (GSSG) was coupled with palmitic acid in the same manner as used for amino acids, as described above. Oxidized palmitoyl glutathione (PGSSGP) was reduced with NaBH4. The reaction mixture was adjusted to pH 1 with 10% HO, then condensated. Water was added to the residue and the mixture was filtered. The product was recrystallized from Me0H-H20 several times. Palmitoyl glutathione (PGSH) was obtained in 49.8% yield (mp 170-171 °C). These compounds was checked by infrared (IR) spectrometry, mass spectrometry and elemental analysis. The results of elemental analyses are shown in Table I .
Preparation of Liposomes Liposomes were prepared by the conventional lipid-film-hydration method.2) In the case of lipid with low solubility in CHC13, Me0H was used as the solvent. The lipid composition of the liposomes was palmitoyl residue of palmitoyl amino acid or palmitoyl glutathione and cholesterol (CH) in a molar ratio of 2: 1 and the lipid concentration was 60 ymol/m1 as total lipids. Liposomes used for biological experiments were sonicated with a bath-type sonicator (Tocho IUC-2811, Tokyo) for 2 h at 0 °C after preparation as above.
[14C]Sucrose and 5(6)-carboxyfluorescein (CF) were used as aqueous markers in the encapsulation study and stability study, respectively. The fluorescent marker (CF) provides an immediate and easily measurable index of membrane permeability and has been widely used for stability studies.20) Unencapsulated marker was removed by dialysis in cellulose tubing.
[3H]Inulin was used as a marker in the in vivo behavior study, and dialysis was carried out in a flowtype dialysis cell with a polycarbonate membrane (Nucleopore Co., CA) having a pore size of 0.05 pm as presented in the previous paper.3) Inulin is considered to be a suitable liposomal marker for in vivo disposition studies, because it is recognized to be biologically inactive and excreted rapidly and completely. 17) Stability in Plasma A 0.1 ml aliquot of the liposome (sonicated) suspension containing 100 mm CF was incubated with 0.9 ml of fresh rat plasma at 37 °C. After appropriate time intervals, a 10 tl aliquot of the incubation mixture was transfered into a tube containing 5.0 ml of cold phosphate-buffered saline (PBS). A 1 ml aliquot of the diluted mixture was treated with Triton X-100. The latency of the liposomes was calculated from the fluorescence intensities with and without Triton X-100 treatment.
Blood Concentration and Urinary Excretion Male albino Wistar rats (body weight; 250 ± 20 g) were cannulated in the femoral vein, femoral artery and bladder, and treated as described in the previous paper.17) A 0.5 ml aliquot of the liposome suspension (30 ,umol total lipids) was injected through the cannula inserted into the femoral vein. At appropriate times after injection, arterial blood and urine samples were collected and the radioactivity of [3H]inulin was counted as described in a previous paper.17 ) Tissue Distribution Immediately after the last sampling of blood and urine (4 h after injection), the animal was sacrificed and the liver, lungs, spleen and kidneys were isolated. The remaining radioactivity of [3H]inulin in each organ was counted as described in a previous paper.'" Transport of Glutathione into the Liver Transport of glutathione into the liver was examined in terms of the suppressing effect on the increase of plasma GOT induced by a high dose of acetaminophen.15) Male ddY mice (body weight; 25-30 g) were given acetaminophen intraperitoneally at the dose of 500 mg/kg in dimethylsulfoxide solution (250 mg/ml). More acetaminophen (same dose) was injected at 1.5 h after the first injection in order to confirm the increase of plasma GOT. Various preparations of sonicated liposomes were injected intravenously at 30 min before the first injection of acetaminophen. The animal was sacrificed by puncturing the jugular vein under light anesthesia with ether at 24 h after the second acetaminophen injection. The blood was sampled rapidly with a heparinized pipet. The activity of plasma GOT was determined by the method of Reitman and Franke122) and expressed in terms of the absorbance of 2,4-dinitrophenylhydrazone at the wavelength of 505 nm.
Results and Discussion
Characterization and Encapsulation Capacity of Liposomes
Optical micrographs of palmitoyl serine liposomes (PSer-liposomes) and palmitoyl glutathione liposomes (PGSH-liposomes) are shown in Fig. 1 . Spherical liposomal structures were observed. Liposomes composed with other palmitoyl amino acids showed similar spherical structure.
The values of encapsulation ratio of aqueous rCisucrose solution in the liposomes calculated from the radioactivity of the suspension after and before dialysis are shown in Table II . Liposomes based on palmitoyl amino acid or palmitoyl glutathione showed an encapsulation capacity for aqueous marker that was comparable to that of phosphatidylcholine liposomes (PC-liposomes) with cholesterol. On the other hand, they showed no encapsulation capacity without cholesterol. This result indicates that these compounds form a lamellar structure encapsulating an aqueous phase, like liposomes, when cholesterol is present. However, they do not form such a structure without cholesterol. Therefore, the lamellar structure was suggested to be stably constructed with alternate hydrophobic anchors of palmitoyl chain and cholesterol in the lipid layer. In the case of sonicated liposomes, their encapsulation ratios were about 1%, comparable to that of sonicated PC-liposomes. Very small particles were observed by optical microscopy. The palmitoyl compounds seem to form very small liposomes and retain their barrier function even after sonication. Small liposomes are advantageous for interaction with the hepatocytes because they are able to pass through the fenestration of the liver sinusoids,12'13) and therefore the sonicated liposomes were used in the following experiments.
Stability in Plasma
It is known that liposomes are destroyed in the blood and release the entrapped aqueous Liposomes were prepared by the lipid-film-hydration method and were composed of palmitoyl compound (as palmitoyl residue) and cholesterol in a molar ratio of 2: 1 (1 div. =-1.67 pm). contents. 16, 17) For the application of the vesicles described here as drug carriers in vivo, they must be stable in plasma. The stabilities of the sonicated PSer-liposomes and PGSHliposomes in fresh plasma were examined and compared with that of PC-liposomes. The results are shown in Fig. 2 as the time course of latency during incubation with fresh rat plasma at 37 °C. PC-Liposomes showed gradual degradation followed by a plateau latency of 85%. On the other hand, PSer-liposomes were very stable and showed little leakage during incubation for 2 h. They showed a leakage of about 6% even at the first sampling time (1.5 min), but this is considered to be due to the adsorbed dye on the liposome surface or very rapid leakage because of temperature shock at the initiation of the incubation, or some other such mechanisms. PGSH-Liposomes showed a degradation profile similar to that of PCliposomes and they are considered to have comparable stability to PC-liposomes in plasma.
Clearance from the Blood Clearance of the sonicated liposomes from the blood after intravenous injection is shown in Fig. 3 . PC-Liposomes were retained in the blood for a long time, and radioactivity amounting to about 2.4% of injected dose was observed in 1 ml of the blood even at 4 h after the injection. This value corresponds to about 50% of dose in whole blood (blood volume was estimated as 8% of body weight). On the other hand, PSer-liposomes and PGSH-liposomes were cleared rapidly and little radioactivity was observed in the blood even at 1 h after injection. In particular, PSer-liposomes were cleared very rapidly and only 1.9%/m1 of the injected radioactivity was observed at 3 min after the injection. It is known that the clearance of liposomes is affected by particle size.17) The size of particles used in this experiment were not determined, but there should not be much difference between PC-and palmitoylcompound-liposomes because they were prepared by the same procedure and the particle sizes were confirmed to be very small by optical microscopy. Therefore, it is reasonable to consider that the clearance mechanisms of the PC-liposomes and synthetic liposomes presented here may be different.
Excretion of an Aqueous Marker in Urine
Cumulative radioactivity excreted in urine after intravenous injection of the liposomes is presented in Fig. 4 as a percentage of the injected dose. The initial increasing phase in the Liposomes were prepared by the sonication procedure and their lipid compositions were the same as those in Fig. 1 . Latency was calculated from the fluorescence intensity of CF lost from the liposomes during incubation with fresh rat plasma at 37 °C. cumulative excretion curve may represent the rapid leakage of the aqueous marker, [3H]inulin, from the liposomes in the circulation as described in the previous paper.17) PSerLiposomes showed a large excretion in the initial phase, even though the in vitro stability study in fresh plasma showed that the liposomes were very stable, as mentioned previously. This result suggests the possibility that the in vivo stability in the early stage after the injection is affected by some other factor(s) than those existing in plasma, e.g. turbulence of the blood flow, interaction with cells in the blood or tissues, etc. PC-Liposomes and PGSH-liposomes seemed to be resistant to these factor(s) and showed lower urinary excretion.
Tissue Distributions
Remaining radioactivity in each organ at 4 h after injection is listed as a percentage of the injected dose in Table III . It is known that intravenously injected liposomes accumulate in the liver and spleen.'" In the present experiment, 23.6% of dose was found in the liver and 8.7% in the spleen after injection of PC-liposomes. Little radioactivity was found in the kidneys and lungs (less than 1%). In the case of PSer-liposomes, 30.1% and 1.8% of the dose were found in the liver and spleen, respectively. Radioactivities in the kidneys and lungs were very low ( < 0.4%). The most remarkable difference between PC-liposomes and PSer-liposomes was in the accumulation in the spleen. PSer-Liposomes showed less accumulation than PC-liposomes (about one-fifth of that of PC-liposomes). The tissue distribution pattern of PGSH-liposomes was very similar to that of PSer-liposomes except for the liver. PGSH-liposomes accumulated in the liver more markedly than PSer-liposomes (67.4% of dose).
The results obtained in this experiment indicated that the liposomes based on palmitoyl amino acid or palmitoyl peptide are selectively accumulated in the liver, not in the spleen, and their blood concentration is very low after intravenous administration. Though PSerliposomes are less stable in the circulation and their aqueous contents are rapidly excreted in the urine, the synthetic liposomes described here may be useful for targeting to the liver. It is not yet clear how the properties (stability and in vivo behavior) of the liposomes described above are related to the species of amino acid or the length of amino acid sequence. This is currently under study.
Transport of Glutathione into the Liver PGSH-Liposomes accumulate in the liver after intravenous injection as described above. The effectiveness of the liposomes as transporters of glutathione to prevent liver necrosis was examined in termes of their suppressing effect on the increase of plasma GOT induced by a high dose of acetaminophen. The results are expressed as absorbance determined by the method of Reitman and Franke1, 22) as shown in Table IV. PGSH-Liposomes containing phosphatidylcholine in an equimolar ratio showed remarkable suppression of the increase of plasma GOT (p < 0.01). PC-Liposomes containing free glutathione in the aqueous phase were also slightly effective (p <0.05). However, PGSHliposomes without phosphatidylcholine were not effective (p> 0.05). Though it is not clear whether the accumulated PGSH-liposomes in the liver are taken up by the Kupffer cells or parenchymal cells, the results obtained in this experiment suggest that glutathione was transferred into the parenchymal cells. Uptake of small liposomes by the parenchymal cells has been reported,12' 13) so the sonicated PGSH-liposomes may be directly taken up by the cells. It is uncertain whether the suppressing effect observed in this study is attributable to acylated glutathione or hydrated free glutathione. However, Anderson et al.1°1 reported the conversion of the glutathione ester to the free form in the cells, so free glutathione might be the effective agent in this case. Phosphatidylcholine seems to be indispensable for the effectiveness of glutathione or palmitoyl glutathione in liposomal form and it may play an important role in the uptake of the liposomes. A study of the liposome-cell interaction should yield interesting results. 
